Clinical Trials Logo

Clinical Trial Summary

The aim of this study was to characterize pharmacokinetics of fentanyl during and after Living Donor Liver Transplantation (LDLT), using population pharmacokinetic analysis with non linear mixed effects modeling.


Clinical Trial Description

Patients received an initial intravenous bolus of fentanyl 100 μg and infused at variable rates ranging from 250 to 400 μg/hr.

Arterial blood samples (3ml) were taken immediately before the start of infusion (baseline), and at scheduled time which were coincident with laboratory tests during surgery as follows. In pre-anhepatic phase, blood were taken at 10min, 30min, 1hr, 3hr, 5hr until clamping of the hepatic blood supply and venous drainage, after the star of anhepatic phase, blood were taken at 5 min, 10 min, 30 min, 60 min, 90 min, 2hr until the vessels were reconnected to new liver. In neo-hepatic phase, blood were taken at 5min, 10min, 30min, 60min, 90min, 2hr, 3hr, 5hr until fentanyl-infusion stop, and at 0hr, 1hr, 3hr, 5hr, 8hr, 12hr, 24hr immediately after the stop of infusion. Samples were collected into tubes containing heparin as an anticoagulant and immediately placed on ice. After centrifugation for 8 min at 1800 g, the plasma was transferred to a cryovial and stored at -70°C until assay. ;


Study Design

Allocation: Non-Randomized, Endpoint Classification: Pharmacokinetics Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms

  • Living Donor Liver Transplantation

NCT number NCT01144312
Study type Interventional
Source Asan Medical Center
Contact
Status Completed
Phase N/A
Start date September 2009
Completion date October 2010

See also
  Status Clinical Trial Phase
Completed NCT00994981 - Magnesium Administration in Liver Transplantation and Reperfusion Injury Phase 4
Not yet recruiting NCT04988100 - Impact of Splenic Artery Ligation in LDLT for Patients With Portal Hypertension N/A
Completed NCT05506020 - Application of ICG Fluorescence Cholangiography in Laparoscopic Living Donor Left Lateral Sectionectomy N/A
Recruiting NCT05431361 - PRehab tO PreparE Living Liver Donors for Enhanced Recovery N/A
Recruiting NCT04909645 - A Comparison of Invasive and Non-invasive Measurement of CI and SVR in Liver Transplantation N/A
Recruiting NCT01907750 - Transcystic Versus Transanastomotic Tube Drainage in Right Lobe LDLT Phase 3
Completed NCT04184401 - Effect of Ascites Replacement Strategy on Time to 1st Flatus After LDLT Phase 4
Completed NCT02990351 - Efficacy of Loco-regional Treatment for Hepatocellular Carcinoma Prior to Living Donor Liver Transplantation in Egypt N/A
Active, not recruiting NCT04208919 - Delayed Infusion of DCreg in Living Donor Liver Transplantation Phase 1/Phase 2
Completed NCT03773276 - Norepinephrine Boluses in Liver Transplantation Phase 1/Phase 2
Active, not recruiting NCT03164265 - DCreg in Living Donor Liver Transplantation Phase 1/Phase 2
Not yet recruiting NCT04943263 - A Comparison of Temperature Measurement During Living Donor Liver Transplantation N/A
Completed NCT05010941 - Hypotension Prediction Index in Living Donor Liver Transplantation